Thursday, October 13, 2005
Now, having worked in the biotech/pharmaceutical industry, I am sympathetic to the notion that it is very very hard to get a new drug to market and that the company that does so should be able to make themselves a nice profit from all the hard work they did to find and test the drug in the first place. But. But in this particular case, where a rapid response with large amounts of the drug could prevent literally millions of deaths, it is my, not even mildly humble, opinion that the people running Roche have their heads up their respective asses. The article mentions that the proposed licensing scheme includes royalty payments to Roche. But Roche wants to sit on their Intellectual Property and so protect their profit margins.
In the event that Great Dying does occur, I hope that the (well dosed with Tamiflu I assume) people in charge of Roche are able to talk their way out of the confrontation with the mob of survivors that will come after them.
Links to this post: